glp-1 diarrhea class action in louisiana Lawyer A drug called apitegromab may

Contact the Ozempic Lawyers at TorHoerman Law for a free consultation

*These statements have not been evaluated by the Food and Drug Administration and are supplements, not prescriptions designed to treat medical conditions

Healthcare professionals should remain alert to emerging evidence in this rapidly evolving field whilst maintaining focus on proven therapeutic approaches

doi: 10.1055/s-0042-109065 Summary Keywords diabetes mellitus type 2, cardiovascular disease, cardiovascular risk, diabetic kidney disease, sodium-glucose cotransporter-2 inhibitor, glucagon-like peptide-1 receptor agonist, aldosterone, renin Citation Puglisi S, Rossini A, Poli R, Dughera F, Pia A, Terzolo M and Reimondo G (2021) Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System